Last Updated on October 23, 2024 by The Health Master
Adverse Event
The Materiovigilance Programme of India (MvPI), a crucial initiative under the Indian Pharmacopoeia Commission (IPC), has introduced a revised medical device adverse event reporting form.
This updated form aims to streamline the reporting process for manufacturers, importers, distributors, and healthcare professionals, ensuring timely and efficient communication of adverse events related to medical devices.
Key Updates in the New Reporting Form
- Enhanced Clarity and Structure: The revised form offers a more user-friendly layout and clear instructions, facilitating accurate and comprehensive reporting.
- Expanded Scope: The form now covers both medical devices and in vitro diagnostics, ensuring a broader range of adverse events are captured.
- Detailed Information Requirements: The form includes specific fields for essential details such as device risk classification, refurbishment history, manufacturer or importer licensing, and event description.
- Comprehensive Assessment: A dedicated section for medical device adverse event assessment allows for in-depth analysis of the incident, including immediate actions taken, suspected root causes, and reporter’s opinion.
Reporting and Confidentiality
The updated form can be submitted electronically to the IPC or sent as a hard copy.
Importantly, the MvPI emphasizes that reporting an adverse event does not imply any legal liability for the reporter.
Patient and reporter confidentiality is strictly maintained, ensuring protection of personal information.
Regulatory Compliance and Importance of Reporting
The release of the new reporting form aligns with the Indian government’s efforts to strengthen the medical device regulatory framework.
All medical devices, including in-vitro diagnostics, now fall under the purview of the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017, requiring mandatory licensing for import or manufacturing.
Timely reporting of adverse event is crucial for ensuring the safety and performance of medical devices.
It enables manufacturers and regulatory authorities to identify potential risks, analyze their frequency, and implement appropriate mitigation measures.
The MvPI plays a pivotal role in collecting, analyzing, and disseminating information on adverse events, contributing to the overall improvement of patient safety.
In conclusion, the updated medical device adverse event reporting form from the MvPI represents a significant step towards enhancing patient safety in India.
By streamlining the reporting process and promoting timely communication of adverse events, this initiative empowers healthcare professionals and manufacturers to proactively address potential risks and ensure the quality of medical devices available in the market.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
IPC to organize webinar on Key role of medical device industry in MvPI
USFDA inspection concluded at Alembic Pharma with no observation
Govt to amend Drugs Rules to crack down on Fake Documents
USFDA approval granted for generic Cetirizine tablets
Cosmetic Labels: DCC suggests BIS Standards
Govt to Mandate QR Codes on All Anti-Cancer Drugs to Combat Counterfeit Crisis
Need for Regulatory Reforms to improve contraceptive access and workforce participation
USFDA approval granted for Lamotrigine Extended-Release Tablets USP
Nutraceutical Industry seeks separate Regulatory Agency
Boosting Drug Regulatory Efficiency: DCC recommends for Training and Development
CDSCO Gains Global Recognition: Milestone for Indian Medical Device Industry
